By uniting with publicly traded Aduro, Versant Ventures-incubated kidney company Chinook will gain a clinical asset for IgA nephropathy while also delivering liquidity to a VC syndicate that is committing additional capital to fund the...

After Third Rock Ventures incubated Maze Therapeutics for two years, the company debuted Thursday with $191 million and plans to generate data for its three genetic modifier programs in the next 3-5 years. Third Rock...

In its $50 million tie-up with the Broad Institute of MIT and Harvard , Deerfield Management is looking to forge a new mold of partnership with an academic organization that allows it to efficiently survey early...

Gene therapy company Homology Medicines Inc. (Lexington, Mass.) raised $83.5 million in a series B round led by Deerfield Management. Existing investors 5AM Ventures , Arch Venture Partners and Temasek participated, as well as new investors...

A year after being spun out from 5AM Ventures’ incubator, Homology Medicines Inc. is showing the first fruits of its $43.5 million series A round with efficacy data on its gene editing adeno-associated viral (AAV)...

While more VCs have created venture incubators to nurture early concepts into full-fledged start-ups, they are aligned more on the need to incubate than on how best to do it. Indeed, a collection of VCs...

Gene editing company Homology Medicines Inc. spun out of 5AM Ventures' incubator with a $43.5 million series A round led by 5AM and Arch Venture Partners. Temasek, Deerfield and Arch Overage Fund also participated. Homology's...

Homology Medicines Inc. is set to spin out of 5AM Ventures ' incubator this week with a $43.5 million series A round and a gene editing platform that could be the first to provide targeted...

Fe3 Medical Inc. , San Antonio, Texas Business: Hematology Date completed: 2016-03-02 Type: Venture financing Raised: $11 million Investors: Jianmin Pharmaceuticals; HG Capital; Ping An Ventures; InCube Ventures WIR Staff Hematology...

Rani Therapeutics LLC , San Jose, Calif. Business: Drug delivery Date completed: 2015-05-26 Type: Venture financing Raised: Not disclosed Investors: Novartis AG ; Google Ventures; InCube Ventures; VentureHealth; Stevanato Group; Crystal Horizon Investments; Pinemount Investments; Pacific...